Haydee Ojeda-Fournier

Haydee Ojeda-Fournier

Auto-generated profile, based on publicly available information

Haydee Ojeda-Fournier

Breast Imaging Division, Department of Radiology, UC San Diego Health, Koman Family Outpatient Pavilion, 9400 Campus Point Dr, La Jolla, CA 92037

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in RadioGraphics
Verified
Journal Article
Closed access
ARAjay Aroor Rao
Ajay Aroor Rao
JFJennifer Feneis
Jennifer Feneis
CLChloe Lalonde
Chloe Lalonde
HOHaydee Ojeda-Fournier
Haydee Ojeda-Fournier
Initially developed in 1993, the American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) lexicon serves to standardize breast imaging reports, improve communication with referring physicians, and provide a quality assurance tool. The long-awaited BI-RADS fifth edition consolidates, improves, and expands the lexicon for mammography, breast ultrasonography (US), and breast magnetic resonance (MR) imaging. The new edition has increased the number of imaging examples to nearly 600. The breast MR imaging lexicon is significantly expanded since it first appeared in the fourth edition. New terms have been added to the US lexicon to reflect technologic advances. Minor but important changes have been made to the mammography section. Calcification descriptors in the lexicon are now consolidated into two categories: benign and suspicious. The controversial “intermediate concern” grouping has been eliminated, and a table in the lexicon summarizes the literature supporting the recommendation t...

1 January 2017 in Academic Radiology
Verified
Journal Article
Closed access
ALAmie Y. Lee
Amie Y. Lee
DWDorota J. Wisner
Dorota J. Wisner
SAShadi Aminololama-Shakeri
Shadi Aminololama-Shakeri
VAVignesh A. Arasu
Vignesh A. Arasu
SFStephen A. Feig
Stephen A. Feig
BJBonnie N. Joe
Bonnie N. Joe

1 October 2007 in RadioGraphics
Verified
Journal Article
Closed access
HOHaydee Ojeda-Fournier
Haydee Ojeda-Fournier
KCK. Ann Choe
K. Ann Choe
MMMary C. Mahoney
Mary C. Mahoney
Magnetic resonance (MR) imaging of the breast has evolved into an important adjunctive tool in breast imaging with multiple and ever-increasing indications for its use. As with other types of MR imaging, there are a number of technical artifacts and pitfalls that can potentially limit interpretation of the images by masking or simulating disease. Because of the coils and computer-aided detection software specific to breast MR imaging, there are additional technical considerations that are unique to this type of MR imaging. Motion and misregistration artifacts, wraparound artifact, susceptibility artifact, poor fat saturation, lack of contrast material, and poor timing of the contrast material bolus are some of the artifacts and pitfalls that can make interpretation of breast MR images challenging and lead to misdiagnosis. Other important considerations in proper interpretation of breast MR images include acquisition of a sufficient medical history, knowledge of benign and abnormal lesion enhancement, morphologic versus kinetic assessment, evaluation of areas outside the breast, and positioning. By using the recommended strategies, one can reduce or eliminate common artifacts and pitfalls in breast MR imaging that prevent proper interpretation of the results of this important diagnostic tool.

24 August 2021 in Radiology
Verified
Journal Article
Closed access
NONatsuko Onishi
Natsuko Onishi
WLWen Li
Wen Li
DNDavid C. Newitt
David C. Newitt
RHRoy J. Harnish
Roy J. Harnish
FSFredrik Strand
Fredrik Strand
NHNola Hylton
Nola Hylton
Lack of background parenchymal enhancement suppression at breast MRI during neoadjuvant chemotherapy may indicate inferior treatment response in hormone receptor–positive breast cancer. Background Suppression of background parenchymal enhancement (BPE) is commonly observed after neoadjuvant chemotherapy (NAC) at contrast-enhanced breast MRI. It was hypothesized that nonsuppressed ...

1 July 2022 in RadioGraphics
Verified
Journal Article
Closed access
PMPaul Manning
Paul Manning
SFSoudabeh Fazeli
Soudabeh Fazeli
VLVivian Lim
Vivian Lim
WLWilliam A. Ladd
William A. Ladd
MEMohammad Eghtedari
Mohammad Eghtedari
HOHaydee Ojeda-Fournier
Haydee Ojeda-Fournier
Invasive lobular carcinomas have an atypical clinical manifestation and imaging appearance, and mammographic, US, and MRI findings can help radiologists accurately assess tumor size and evaluate fo...

4 November 2020 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
MAMaren M. Sjaastad Andreassen
Maren M. Sjaastad Andreassen
ARAna E. Rodríguez-Soto
Ana E. Rodríguez-Soto
CCChristopher C. Conlin
Christopher C. Conlin
IVIgor Vidić
Igor Vidić
TSTyler M. Seibert
Tyler M. Seibert
ADAnders M. Dale
Anders M. Dale
Purpose: Diffusion-weighted MRI (DW-MRI) is a contrast-free modality that has demonstrated ability to discriminate between predefined benign and malignant breast lesions. However, how well DW-MRI discriminates cancer from all other breast tissue voxels in a clinical setting is unknown. Here we explore the voxelwise ability to distinguish cancer from healthy breast tissue using signal contributions from the newly developed three-component multi-b-value DW-MRI model. Experimental Design: Patients with pathology-proven breast cancer from two datasets (n = 81 and n = 25) underwent multi-b-value DW-MRI. The three-component signal contributions C1 and C2 and their product, C1C2, and signal fractions F1, F2, and F1F2 were compared with the image defined on maximum b-value (DWImax), conventional apparent diffusion coefficient (ADC), and apparent diffusion kurtosis (Kapp). The ability to discriminate between cancer and healthy breast tissue was assessed by the false-positive rate given a sensitivity of 80% (FPR80) and ROC AUC. Results: Mean FPR80 for both datasets was 0.016 [95% confidence interval (CI), 0.008–0.024] for C1C2, 0.136 (95% CI, 0.092–0.180) for C1, 0.068 (95% CI, 0.049–0.087) for C2, 0.462 (95% CI, 0.425–0.499) for F1F2, 0.832 (95% CI, 0.797–0.868) for F1, 0.176 (95% CI, 0.150–0.203) for F2, 0.159 (95% CI, 0.114–0.204) for DWImax, 0.731 (95% CI, 0.692–0.770) for ADC, and 0.684 (95% CI, 0.660–0.709) for Kapp. Mean ROC AUC for C1C2 was 0.984 (95% CI, 0.977–0.991). Conclusions: The C1C2 parameter of the three-component model yields a clinically useful discrimination between cancer and healthy breast tissue, superior to other DW-MRI methods and obliviating predefining lesions. This novel DW-MRI method may serve as noncontrast alternative to standard-of-care dynamic contrast-enhanced MRI.